@article{5d72a24694324123ac1e90978917502c,
title = "Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab",
abstract = "N/A",
keywords = "Angiogenesis Inhibitors, Fluorescein Angiography, Follow-Up Studies, Fundus Oculi, Humans, Infant, Newborn, Intravitreal Injections, Male, Ranibizumab, Recurrence, Retina, Retinopathy of Prematurity, Time Factors, Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors, Fluorescein Angiography, Follow-Up Studies, Fundus Oculi, Humans, Infant, Newborn, Intravitreal Injections, Male, Ranibizumab, Recurrence, Retina, Retinopathy of Prematurity, Time Factors, Vascular Endothelial Growth Factor A",
author = "Fernando Molle and Domenico Lepore and Amorelli, {Giulia Maria} and Ji, {Marco H.} and Moshfeghi, {Darius M.} and Callaway, {Natalia F.} and Zachary Bodnar and Schachar, {Ira H.} and Lorenzo Orazi",
year = "2019",
doi = "10.1016/j.oret.2019.06.017",
language = "English",
volume = "3",
pages = "913--915",
journal = "Ophthalmology Retina",
issn = "2468-7219",
publisher = "Elsevier Inc.",
}